VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: Implications in the pathogenesis of preeclampsia

Laboratory Investigation

Volumn 79, Issue 9, 1999, Pages 1101-1111

  Brockelsby, Jeremy ^b   Hayman, Richard ^b   Ahmed, Asif ^a   Warren, Averil ^b   Johnson, Ian ^b   Baker, Philip ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MYOGRAPHY; MYOMETRIUM; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEINURIA; RECEPTOR AFFINITY; VASCULAR RESISTANCE;

ADOLESCENT; ADULT; ANTIBODIES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOKINES; MYOMETRIUM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATION;

EID: 0032852892     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Alfredo N, Sibai BM, Barton JR, Meller BM, and Mitchell M (1991). Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 165:724-727.
2. Anthony FW, Evans PW, Wheeler T, and Wood PJ (1997). Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 34:276-280.
3. Arai H, Hori S, Aramori I, Ohkubo H, and Nakanishi S (1991). Cloning and expression of cDNA encoding an endothelin receptor. Nature 348:730-732.
4. Ashworth JR, Warren AY, Baker PN, and Johnson IR (1997). Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 104:1152-1158.
5. Ashworth JR, Warren AY, Johnson IR, and Baker PN (1998). Plasma from pre-eclamptic women induces a functional changes in myometrial resistance arteries. Br J Obstet Gynaecol 105:459-461.
6. Baker PN, Davidge ST, Barankiewicz J, and Roberts JM (1996). Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 27:56-61.
7. Baker PN, Davidge ST, and Roberts JM (1995a). Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 26:244-248.
8. Baker P, Krasnow J, Roberts J, and Yeo K-T (1995b). Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86:815-821.
9. Branch DW, Dudley DJ, and Mitchell MD (1991). Preliminary evidence for homeostatic mechanism regulating endothelin production in preeclampsia. Lancet 337:943-945.
10. Brockelsby JC, Anthony F, Johnson IRJ, Wheeler T, and Baker PN (1998). Elevated serum vascular endothelial growth factor concentrations in preeclampsia. Hypertens Pregnancy 17:283-290.
11. Brosens IA (1977). Morphological changes in the uteroplacental bed in pregnancy hypertension. Clin Obstet Gynecol 77:573-593.
12. Brown MA, Zammit VC, and Lowe SA (1989). Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci 599-604.
13. Charnock-Jones D, Clark DE, He YL, Licence DR, and Smith SC (1997). Placental production of a locally and systemically acting soluble factor which inhibits vascular endothelial growth factor (VEGF) (Abstract). J Soc Gynecol Invest 4:189A.
14. Clark BA, Halvorson L, Sachs B, and Epstein FH (1992). Plasma endothelin levels in preeclampsia: Elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol 166:962-968.
15. Clauss M, Gerlach M, and Gerlach H (1990). Vascular permeability factor: A tumor derived poly-peptide that induces endothelial cells and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 172:1535-1545.
16. Davey DA and MacGillivary I (1988). The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892-898.
17. Ferrara N, Houck K, Jakeman L, and Leung D (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
18. Jackson MR (1994). Localisation of two angiogenic growth factors (PDECGF and VEGF) in human placenta throughout gestation. Placenta 15:341-353.
19. Jaye M, Howk R, Burgess W, Ricca G, Chin I, Ravera M, O'Brien S, Modi W, Macing T, and Drohar W (1986). Human endothelial cell growth factor: Nucleotide sequence and chromosome function. Science 233:541-545.
20. Lunell NO, Lewander R, Mamoun I, Nylund L, Sarby S, and Thornstrom S (1984). Uteroplacental blood flow in pregnancy induced hypertension. Scand J Clin Lab Invest Suppl 169: 28-35.
21. Lyall F, Greer IA, Boswell F, and Fleming R (1997). Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol 104:223-228.
22. Maeckj JVS and Zilliacus H (1948). Heparin in treatment of toxemia and pregnancy: Preliminary report. Am J Obstet Gynecol 55:326-331.
23. Masabum S (1993). Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 69:281 G-316G.
24. Matsuura A, Kawashima S, Yamochi W, Hirata K, Yamaguchi T, Emoto N, and Yokoyama M (1997). Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells. Biochem Biophys Res Commun 235:713-716.
25. McCarthy AL, Woolfson RG, Raju SK, and Poston L (1993). Abnormal endothelial cell function of resistance arteries in women with pre-eclampsia. Am J Obstet Gynecol 168:1323-1330.
26. McCartney CP (1969). The acute hypertensive disorders of pregnancy, classified by renal histology. Gynaecologia 167: 214-220.
27. Mulvany MJ and Halpen W (1976). Mechanical properties of vascular smooth muscle cells in situ. Nature 260:617-619.
28. Nawroth P and Stern D (1988). Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 164:470-475.
29. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, and McLaughlin MK (1989). Pre-eclampsia: An endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204.
30. Senger D, Galli S, Dovorak A, Perruzzi C, Harvey V, and Dovorak H (1983). Tumor cells secretes a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
31. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DS, Charnock-Jones DS, Morris NH, and Smith SK (1996). Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 26:1182-1185.
32. Shweiki D, Itiw A, Soffer D, and Kesnet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
33. Stark J (1993). Pre-eclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 100:105-109.
34. Svane D, Skajaa K, Andersson K-E, and Forman A (1991). Vascular responses in term pregnant and non-pregnant human uterus. Placenta 12:47-54.
35. Taylor RN, Crombleholme MD, Friedman SA, Jones LA, Casal D, and Roberts JM (1991). High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 165:895-901.
36. Uchida K, Uchida S, Nitta K, Yamura W, Marumo F, and Nihei H (1994). Glomerular endothelial cells in culture express and secrete VEGF. Am J Physiol 266:F81-F88.
37. Waltenberger J, Mayr U, Pentz S, and Hombach V (1996). Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94:1647-1654.
38. Warren AY, Ashworth JR, Wellings RP, Baker PN, and Johnson IR (1997). Endothelin-1 in human myometrial resistance arteries (Abstract). Hypertens Pregnancy 16:327.